# GMS Taiwan and Nihon Medi-Physics sign FACBC development and distribution agreement

Global Medical Solutions Taiwan and Nihon Medi-Physics Co. Ltd. entered an exclusive agreement to develop and commercialize FACBC, a PET imaging agent for recurrent prostate cancer, in Taiwan. GMS Taiwan will submit the marketing authorization application and manufacture and distribute the product upon approval.

- Type: Partnership
- Announced: 2018-11-19
- Where: Taiwan, TWN
- Status: announced
- Products: FACBC (Axumin) PET imaging agent
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Global Medical Solutions Taiwan](https://endata.com/companies/35627.md)
- [Nihon Medi-Physics Co. Ltd.](https://endata.com/companies/35628.md) (partner)

## Sources

- [globalmedicalsolutions.com](https://globalmedicalsolutions.com/2018/11/22/gms-taiwan-signs-facbc-joint-development-and-distribution-agreement-with-nihon-medi-physics-co-ltd-to-develop-and-commercialize-facbc-axumin/), 2018-11-22: "FACBC fits perfectly in our product portfolio by strengthening our offering in PET imaging agents for use in oncology"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.